ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 88 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $15,000 | -51.6% | 3,994 | -22.1% | 0.00% | – |
| Q4 2019 | $31,000 | 0.0% | 5,128 | +23.4% | 0.00% | – |
| Q3 2019 | $31,000 | -34.0% | 4,155 | +20.1% | 0.00% | – |
| Q2 2019 | $47,000 | +123.8% | 3,460 | +42.0% | 0.00% | – |
| Q1 2018 | $21,000 | -30.0% | 2,436 | 0.0% | 0.00% | – |
| Q4 2017 | $30,000 | +114.3% | 2,436 | +45.0% | 0.00% | – |
| Q3 2017 | $14,000 | -53.3% | 1,680 | 0.0% | 0.00% | – |
| Q2 2017 | $30,000 | – | 1,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ground Swell Capital, LLC | 25,445 | $19,000 | 0.05% |
| ETF MANAGERS GROUP, LLC | 2,258,970 | $1,654,000 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 116,780 | $85,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 131,036 | $96,000 | 0.01% |
| Bernardo Wealth Planning LLC | 30,469 | $20,000 | 0.01% |
| PCG Wealth Advisors, LLC | 15,200 | $12,000 | 0.00% |
| Penserra Capital Management LLC | 212,298 | $155,000 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $36,000 | 0.00% |
| King Wealth Management Group | 16,000 | $12,000 | 0.00% |
| Vident Investment Advisory, LLC | 105,398 | $77,000 | 0.00% |